An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme (Q36625937)

15 August 2017

An evaluation of liquid-based cytology and human papillomavirus testing within the UK cervical cancer screening programme (English)

1 reference

15 August 2017

1 reference

cervix uterine cancer

1 reference

inferred from title

author

Chris Sherlaw-Johnson

series ordinal

1

object named as

C Sherlaw-Johnson

1 reference

15 August 2017

Z Philips

2

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

91

1 reference

15 August 2017

1

1 reference

15 August 2017

84-91

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6601884

15 August 2017

0 references

cites work

Management of women who test positive for high-risk types of human papillomavirus: the HART study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Cross sectional study of conventional cervical smear, monolayer cytology, and human papillomavirus DNA testing for cervical cancer screening

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Liquid-based cytology in cervical screening: a rapid and systematic review.

30 September 2017

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

30 September 2017

https://api.crossref.org/works/10.1038%2FSJ.BJC.6601884

7 January 2021

inferred from DOI database lookup

Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: a systematic review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

A systematic review of the role of human papillomavirus testing within a cervical screening programme

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

HPV testing in primary screening of older women

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Withdrawing low risk women from cervical screening programmes: mathematical modelling study

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Present evidence on the value of HPV testing for cervical cancer screening: a model-based exploration of the (cost-)effectiveness

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Can papilloma virus testing be used to improve cervical cancer screening?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Young age as a prognostic factor in cervical cancer: analysis of population based data from 10,022 cases

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Clinical implications of screening for cervical cancer under Medicare. The natural history of cervical cancer in the elderly: what do we know? What do we need to know?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Screening for cervical cancer: is there a place for incorporating tests for the human papillomavirus?

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Human papillomavirus testing in primary cervical screening.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Cost-effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Benefits and costs of using HPV testing to screen for cervical cancer

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Natural history of cervicovaginal papillomavirus infection in young women.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

Variability of human papillomavirus DNA testing in a longitudinal cohort of young women

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2364742

HPV DNA testing in cervical cancer screening: results from women in a high-risk province of Costa Rica

20 September 2018

1 reference

12 December 2020

Persistence of type-specific human papillomavirus infection among cytologically normal women

1 reference

12 December 2020

Human papillomavirus testing by hybrid capture appears to be useful in triaging women with a cytologic diagnosis of atypical squamous cells of undetermined significance

1 reference

12 December 2020

The promise and risk of a new technology: The Lehigh Valley Hospital's experience with liquid-based cervical cytology

1 reference

12 December 2020

Stage-specific treatment costs for cervical cancer in the United Kingdom

1 reference

12 December 2020

Performance of a fluid-based, thin-layer papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6601884

1 reference

release_biwl4ko57jd27lcljjxoq63jsm

15 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/biwl4ko57jd27lcljjxoq63jsm

24 November 2022

mapped directly with Wikidata item

1 reference

15 August 2017

PubMed publication ID

15162150

1 reference